With Buffett stepping down by end-2025, these stocks represent his final legacy as Berkshire's CEO. You're looking at the companies that survived Buffett's notoriously strict selection criteria.
Buffett's investment approach has generated mind-boggling returns over 60 years. These companies are the backbone of a strategy that created a $168.6 billion fortune and outperformed the S&P 500 by 2x annually.
As Buffett famously said, "Our favorite holding period is forever." These aren't trend-chasing stocks but carefully selected businesses built to create value for decades, not just quarters.
This portfolio lets you mirror Warren Buffett's legendary investment approach. With a 60-year track record of 20% annual returns and a staggering 5,500,000% growth in Berkshire shares, Buffett's strategy of buying great companies at fair prices and holding long-term has proven extraordinarily successful.
These stocks reflect Buffett's philosophy of investing in businesses he understands deeply. As the 94-year-old Oracle of Omaha prepares to step down by end-2025, this portfolio offers exposure to the companies that built his $168.6 billion fortune and Berkshire's massive $347.7 billion cash position.
Each company here has earned Buffett's confidence through strong fundamentals, sustainable competitive advantages, and long-term growth potential. From Apple to Coca-Cola, these selections represent Buffett's careful analysis and preference for quality businesses that can withstand market cycles and deliver lasting value.
Follow in the footsteps of Warren Buffett, one of history's greatest investors, with this carefully selected portfolio of his favorite companies. As Buffett prepares to step down as Berkshire's CEO, now's your chance to invest like the Oracle of Omaha.
Summary and key takeaways for a stock basket based on provided market capitalisation breakdown.
AAPL: $3.90T
AXP: $244.69B
KO: $306.39B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+5
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+1.68%
On average, analysts expect assets in this group to grow 1.68% over the next year.
11 of 15 assets in this group are rated Buy by professional analysts.
